The heart effects of antidepressants may depend as much on the patient as the drug
A major analysis of randomized trials tracked changes in heart rhythm across 10 antidepressants and examined how age,…
Can Changing Your Diet Help Fight Depression? Study Shows Promising Link
There are several factors that can cause depression, including genetics, brain chemistry, stress, trauma and life circumstances. Researchers…
Add-on drug lumateperone boosts sexual function in patients with depression
Patients with major depressive disorder (MDD) and an inadequate response to standard antidepressants who received an add- on…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Probiotics for mental health? A new review finds promising signals and major gaps
Researchers map the probiotic strains and gut-brain pathways being investigated across anxiety, depression, bipolar disorder, and schizophrenia, revealing…
Major VA study to examine effectiveness of psilocybin on depression, PTSD
The Department of Veterans Affairs is launching research to determine whether psilocybin — the psychoactive ingredient in “magic…
Depression shapes how children pay attention to emotional faces
A smile. A frown. The faces a child pays closer attention to might offer invaluable insight into their…
Neumora Ends Depression Drug Programme and Announces Workforce Reduction (NMRA)
medical research red syringe NEW SIZE ©rawpixel Neumora Therapeutics (NASDAQ:NMRA) said on Monday that it will halt development…
Ghrelin rises in depression despite obesity’s usual appetite-hormone suppression
A new study finds elevated active and deacylated ghrelin in unmedicated patients with both major depression and obesity,…
How could bisphenol A raise depression risk? Study identifies six key molecular targets
Researchers combined genetic epidemiology, transcriptomics, molecular docking, and mouse experiments to show how a common endocrine-disrupting chemical may…
NOX-1 identified as key molecular target to prolong ketamine’s antidepressant effects
Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief,…
Depression’s “Energy Crisis”: Fatigue Starts at the Cellular Level
Summary: Fatigue is one of the most debilitating and hardest-to-treat symptoms of major depressive disorder (MDD). New research…